Company: SXTPW
Filing Date: 2025-03-27
Form Type: 10-K
Source: 0001013762-25-003343
Chunk: 953

Company: 60 DEGREES PHARMACEUTICALS, INC.
Filing Date: 2025-03-27
Form: 10-K
Item: Item 3
Chunk 953
---
598  
     -  
     7,989,598 
  
    Conversion
    of debt into Series A Preferred Stock upon initial public offering 
     80,965  
     10,128,500  
     -  
     -  
     -  
     -  
     -  
     10,128,500  
     -  
     10,128,500 
  
    Reclassification
    of liability-classified warrants to equity-classified 
     -  
     -  
     -  
     -  
     838,748  
     -  
     -  
     838,748  
     -  
     838,748 
  
    Issuance of common stock pursuant to IPO, net of underwriting discounts, commissions, and deferred offering costs of $1,266,740 
     -  
     -  
     23,585  
     2  
     6,235,274  
     -  
     -  
     6,235,276  
     -  
     6,235,276 
  
    Issuance
    of common stock upon exercise of warrants 
     -  
     -  
     3,075  
     -  
     1,131,771  
     -  
     -  
     1,131,771  
     -  
     1,131,771 
  
    Voluntary
    conversion of Series A Preferred Stock into common stock 
     (2,162) 
     (270,460) 
     760  
     -  
     270,460  
     -  
     -  
     -  
     -  
     - 
  
    Share-based
    compensation under 2022 Equity Incentive Plan 
     -  
     -  
     668  
     -  
     528,926  
     -  
     -  
     528,926  
     -  
     528,926 
  
    Contribution
    from noncontrolling interest 
     -  
     -  
     -